Immuneering Corp Standard Deviation
| IMRX Stock | | | USD 5.23 0.00 0.00% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is Immuneering Corp's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
Immuneering Corp has a Standard Deviation of 3.63, indicating moderate price variability. This places Immuneering Corp within the typical volatility range for Biotechnology.
Standard Deviation | = | SQRT(V) |
| = | 3.63 | |
Standard Deviation Peers Comparison
Relative to peers, Immuneering Corp's Standard Deviation is below the group average of 5.36. Peer readings range from 3.05 (Enanta Pharmaceuticals) to 8.11 (Entrada Therapeutics), reflecting moderate dispersion across the sector. Immuneering Corp has exhibited less price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for Immuneering Corp and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Immuneering Corp's Maximum Drawdown of
18.27 runs about
5.03 times its Standard Deviation of
3.63 . This indicates Maximum Drawdown substantially exceeds Standard Deviation for Immuneering Corp.
Methodology, Assumptions & Data Sources
The current Standard Deviation for Immuneering Corp is 3.63. Immuneering Corp's Standard Deviation is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Immuneering Corp operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators